上海魅丽纬叶医疗科技有限公司
上海魅丽纬叶医疗科技有限公司,一家专注于慢病介入器械治疗突破型企业。
生生物流
公司自2009年成立,是中国医药冷链服务行业的先行者,自成立以来一直专注于为生命科学、生物技术、药物研发、商业成品药等领域的客户,提供全链条一站式医药冷链服务
https://ashsh.cn/
上海优替济生生物医药有限公司
以研发创新改变肿瘤治疗现状,打造中国品牌,成为世界一流的细胞治疗企业
http://utctherapeutics.com
江苏亚虹医药科技股份有限公司
是一家专注于泌尿生殖系统肿瘤及其它重大疾病领域的全球化创新药公司。
Stock Code:688176.SH
www.asieris.cn
长风药业股份有限公司
长风药业专注于呼吸系统细分领域,是一家以国际化市场为导向的集研发、生产和销售于一体高科技制药企业。公司以开发高质量的呼吸系统治疗产品为使命,在哮喘、COPD、过敏性鼻炎等多个临床需求大的治疗领域构建了丰富的研发管线。
http://www.cfpharmtech.com/
德美联合(重庆)医疗科技有限公司
德美联合(重庆)医疗科技有限公司(简称“德美医疗”)是一家集运动医学植入物、手术工具、关节镜设备、运动康复器具和设备的研发、生产、销售、服务于一体的国际化医疗科技集团。
http://www.deltamedical.cn/
爱博诺德(北京)医疗科技股份有限公司
爱博诺德(北京)医疗科技股份有限公司,科创板上市企业,位于北京中关村国家自主创新示范区,是国家级高新技术企业、国家级专精特新“小巨人”企业。公司专注于眼科医疗器械的自主研发、生产、销售及相关服务。
Stock Code:688050.SH
http://www.ebmedical.com/about/#profile
Top

Statement:

It has been discovered that some entities or individuals maliciously impersonate our company and our employees, and conduct illegal financing through live broadcasts on the internet to profit illegally. Such illegal behavior has seriously damaged our image. We kindly remind you not to believe in information released other than our official channels, official channels of Hengxu Capital include - website: www.hengxucapital.com; WeChat account: Hengxu Capital (ID: Hengxucapital). Our solemn statement:

 

1.Illegal behavior carried out by anyone who impersonates our company or our employees will be subject to legal action and take legal responsibility for rights infringement, we pursue protecting the legitimate rights and interests of our company and our personnel. Hengxu Capital will not tolerate such illegal activities, we have taken and will continue to take legal action to pursue the legal responsibility of individuals or entities engaged in such illegal activities.

 

2.Hengxu Capital is a private equity and venture capital fund manager registered with Asset Management Association of China, and conducts business strictly in accordance with relevant regulatory requirements. To avoid losses, we would like to remind investors to be vigilant and invest through legal and legitimate channels, and not believe in false information obtained from non-official channels of Hengxu Capital.

 

3.Thank you for your kind support and attention. If you find any abnormal identity or information, please contact us for verification in a timely manner. At the same time, we encourage you to actively provide information and report aforementioned illegal activities at +86-21-22016849. Victim is requested to report to local police promptly to protect your own interests, and  ensure offenders are held accountable as soon as possible.

 

Shanghai SAIC Hengxu Capital Co., Ltd.

Aug. 22, 2022